Skip to main content
. 2012 Aug 15;2012(8):CD000494. doi: 10.1002/14651858.CD000494.pub4

Egypt 2009.

Methods Double blind, randomised, placebo‐controlled trial.
Participants 514 women with spontaneous normal delivery of a live, singleton neonate, and absence of any contraindications for misoprostol or oxytocin use were included.
The women were excluded if they delivered by caesarean, had a history of antepartum haemorrhage or bleeding tendency, were diagnosed with hypertensive disorder with pregnancy or had the need for anticoagulants.
Interventions 800 mcg rectal misoprostol versus 5 IU of oxytocin in 5 mL lactated Ringer.
Outcomes The primary outcome was the number of patients estimated to have postpartum haemorrhage.
Secondary outcomes were a haematocrit drop of 10% or more 24 hours postpartum; haemoglobin concentration 24 hours postpartum; changes in systolic and diastolic blood pressure; duration of the third stage of labour; need for manual removal of the placenta and/or blood transfusion; additional uterotonics, and nausea, shivering and fever (≥ 38 C) assessed 1 hour postpartum as the adverse effects of misoprostol.
Notes Active management of third stage of labour.
Estimation of blood loss was not done on a quantitative basis; diagnosis of blood loss greater than 500 mL and the decision to apply further measures to control postpartum blood loss were based on a subjective estimation of blood loss by the obstetrician.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "computer generated random allocation system."
Allocation concealment (selection bias) Low risk "sealed, opaque, consecutively numbered and coded envelopes."
Blinding (performance bias and detection bias) 
 All outcomes Low risk Double‐blinded. The randomisation code of data sheets was not broken until completion of the study.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No loss to follow‐up or exclusions reported.
Selective reporting (reporting bias) Low risk Primary outcomes of the review have been reported.
Other bias Low risk 2 groups were comparable at baseline.